-
NBY Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
NovaBay Pharmaceuticals (NBY)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.25 mm | 1.25 mm | 1.25 mm | 1.25 mm | 1.25 mm | 1.25 mm |
Cash burn (monthly) | (no burn) | 200.17 k | 353.67 k | 754.33 k | 687.00 k | 400.25 k |
Cash used (since last report) | n/a | 854.81 k | 1.51 mm | 3.22 mm | 2.93 mm | 1.71 mm |
Cash remaining | n/a | 398.19 k | -257.34 k | -1.97 mm | -1.68 mm | -456.27 k |
Runway (months of cash) | n/a | 2.0 | -0.7 | -2.6 | -2.4 | -1.1 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 3 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 7.00 k |
Total shares | 6.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
NVWM | 3.00 | $2.00 k |
Thrivent Trust Co of Tennessee | 2.00 | $4.00 k |
Addison Advisors | 1.00 | $1.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 May 24 | Yongxiang Zheng | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
28 May 24 | Zheng Yenyou | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
28 May 24 | Wu Mijia | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
28 May 24 | Sit Swan | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
28 May 24 | Freiman Paul E. | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |